Abstract
Gap junction channel selectivity, open probability, and recruitment are properties that affect the transit of solutes from cell to cell. Selectivity is the property of an open channel that acts as a discriminator, allowing the passage of specific solutes while denying transit to others. Open probability is another parameter that can affect the efficiency of cell to cell transit. Channel recruitment is another facilitating mechanism able to affect transit. Rapid alterations in any of these properties suggests that dynamic effects are possible for gap junction channel mediated cell to cell coupling. Suspect modulators presumably capable of effecting dynamic change would be the kinases. The properties of gap junction channels in the context of selectivity, open probability and recruitment are discussed here along with the ability of kinases to affect them. These processes and their regulation are also targets for regulating cell-to-cell communication through therapeutics. Clearly these same properties are ones that disease states might also opportunistically alter to affect physiological processes.
Current Drug Targets
Title: Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?
Volume: 3 Issue: 6
Author(s): Peter R. Brink
Affiliation:
Abstract: Gap junction channel selectivity, open probability, and recruitment are properties that affect the transit of solutes from cell to cell. Selectivity is the property of an open channel that acts as a discriminator, allowing the passage of specific solutes while denying transit to others. Open probability is another parameter that can affect the efficiency of cell to cell transit. Channel recruitment is another facilitating mechanism able to affect transit. Rapid alterations in any of these properties suggests that dynamic effects are possible for gap junction channel mediated cell to cell coupling. Suspect modulators presumably capable of effecting dynamic change would be the kinases. The properties of gap junction channels in the context of selectivity, open probability and recruitment are discussed here along with the ability of kinases to affect them. These processes and their regulation are also targets for regulating cell-to-cell communication through therapeutics. Clearly these same properties are ones that disease states might also opportunistically alter to affect physiological processes.
Export Options
About this article
Cite this article as:
Peter R. Brink , Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?, Current Drug Targets 2002; 3 (6) . https://dx.doi.org/10.2174/1389450023347326
DOI https://dx.doi.org/10.2174/1389450023347326 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulation of Insulin Release at Pre-exocytotic Stages of the Secretory Process
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment
Current Molecular Medicine Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume II)
CNS & Neurological Disorders - Drug Targets Scientific Basis for the Use of Indian Ayurvedic Medicinal Plants in the Treatment of Neurodegenerative Disorders: 1. Ashwagandha
Central Nervous System Agents in Medicinal Chemistry Challenges for the Treatment of Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design Edaravone May Prevent Ferroptosis in ALS
Current Drug Targets Improving Antihypertensive Agent Selection to Promote Nephroprotection
Current Hypertension Reviews Conference Report: 10th International Summer School of Neurology: Celebrating a Decade of Success: 5th July, 2015 – 9th July, 2015 | Eforie Nord, Romania
CNS & Neurological Disorders - Drug Targets A Protective Role of Translocator Protein in Alzheimer’s Disease Brain
Current Alzheimer Research Gene Therapy in Peripheral Nerve Reconstruction Approaches
Current Gene Therapy PKC Delta and Epsilon in Drug Targeting and Therapeutics
Recent Patents on DNA & Gene Sequences Blood Pressure Management in Metabolic Syndrome
Current Hypertension Reviews HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities
Current HIV Research Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Current Neuropharmacology Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease
Current Alzheimer Research Dynamic Role of Microparticles in Type 2 Diabetes Mellitus
Current Diabetes Reviews Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical Biotechnology Application of Resveratrol in Diabetes: Rationale, Strategies and Challenges
Current Molecular Medicine Inhibition of Fungal Aldose Reductase
Protein & Peptide Letters